IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 225 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,948,219 | -35.5% | 242,920 | +19.2% | 0.00% | -100.0% |
| Q1 2024 | $3,019,486 | +62.7% | 203,744 | -10.7% | 0.00% | – |
| Q4 2023 | $1,855,681 | +85.7% | 228,251 | +3.9% | 0.00% | – |
| Q3 2023 | $999,317 | -17.5% | 219,630 | +27.7% | 0.00% | – |
| Q2 2023 | $1,210,719 | +63.1% | 171,977 | +41.6% | 0.00% | – |
| Q1 2023 | $742,236 | -9.9% | 121,479 | -5.7% | 0.00% | – |
| Q4 2022 | $823,524 | -29.8% | 128,877 | +5.2% | 0.00% | – |
| Q3 2022 | $1,173,000 | -15.7% | 122,501 | -2.9% | 0.00% | – |
| Q2 2022 | $1,392,000 | -34.8% | 126,142 | -1.6% | 0.00% | -100.0% |
| Q1 2022 | $2,134,000 | -11.9% | 128,192 | +1.0% | 0.00% | 0.0% |
| Q4 2021 | $2,423,000 | -11.1% | 126,888 | +14.8% | 0.00% | 0.0% |
| Q3 2021 | $2,726,000 | +22.7% | 110,561 | +29.5% | 0.00% | 0.0% |
| Q2 2021 | $2,222,000 | -25.3% | 85,381 | -9.1% | 0.00% | 0.0% |
| Q1 2021 | $2,975,000 | -31.2% | 93,972 | +0.8% | 0.00% | -50.0% |
| Q4 2020 | $4,327,000 | +17.5% | 93,268 | -16.6% | 0.00% | 0.0% |
| Q3 2020 | $3,682,000 | +19.6% | 111,852 | -0.3% | 0.00% | +100.0% |
| Q2 2020 | $3,079,000 | +27.4% | 112,167 | +38.9% | 0.00% | 0.0% |
| Q1 2020 | $2,417,000 | +27.5% | 80,747 | +18.0% | 0.00% | 0.0% |
| Q4 2019 | $1,895,000 | +64.2% | 68,455 | +8.0% | 0.00% | 0.0% |
| Q3 2019 | $1,154,000 | +105.7% | 63,397 | +177.5% | 0.00% | – |
| Q2 2019 | $561,000 | +204.9% | 22,846 | +18.0% | 0.00% | – |
| Q1 2019 | $184,000 | +10.8% | 19,362 | +2.6% | 0.00% | – |
| Q4 2018 | $166,000 | +12.9% | 18,863 | +44.3% | 0.00% | – |
| Q3 2018 | $147,000 | -12.0% | 13,069 | 0.0% | 0.00% | – |
| Q2 2018 | $167,000 | -28.9% | 13,069 | -5.9% | 0.00% | – |
| Q1 2018 | $235,000 | +92.6% | 13,885 | -7.7% | 0.00% | – |
| Q4 2017 | $122,000 | +9.9% | 15,050 | +6.4% | 0.00% | – |
| Q3 2017 | $111,000 | +7.8% | 14,143 | 0.0% | 0.00% | – |
| Q2 2017 | $103,000 | – | 14,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
| Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
| Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
| Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
| Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
| QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
| Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |